We are live on ! Find out more
PCM

Prelude Capital Management Portfolio holdings

AUM $1.31B
1-Year Est. Return 62.01%
This Fund
S&P 500
This Quarter Est. Return
+6.89%
1 Year Est. Return
+62.01%
3 Year Est. Return
+164.15%
5 Year Est. Return
+274.12%
10 Year Est. Return
+2,470.02%
AUM
$1.31B
AUM Growth
-$51.4M
Cap. Flow
-$54.7M
Cap. Flow %
-4.18%
Top 10 Hldgs %
12.11%
Holding
1,682
New
422
Increased
338
Reduced
347
Closed
506

Top Buys

Rank Stock Value
1
PEN icon
Penumbra
PEN
+$15.3M
2
META icon
Meta Platforms (Facebook)
META
+$13.5M
3
CWAN
Clearwater Analytics
CWAN
+$13M
4
APPN icon
Appian
APPN
+$10.6M
5
VSNT
Versant Media Group
VSNT
+$9.37M

Top Sells

Rank Stock Value
1
GLD icon
SPDR Gold Trust
GLD
+$18.2M
2
TER icon
Teradyne
TER
+$15.9M
3
BE icon
Bloom Energy
BE
+$15.3M
4
CYBR
CyberArk
CYBR
+$15.2M
5
EXAS
Exact Sciences
EXAS
+$13.4M

Sector Composition

Rank Sector Weight
1 Technology 22.29%
2 Healthcare 14.62%
3 Consumer Discretionary 10.89%
4 Industrials 8.81%
5 Communication Services 8.36%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AMSF icon
1201
AMERISAFE
AMSF
$543M
– –
-6,913
Closed -$266K
AMWL icon
1202
American Well
AMWL
$180M
– –
-20,605
Closed -$101K
AN icon
1203
AutoNation
AN
$7.11B
– –
-1,508
Closed -$311K
ANF icon
1204
Abercrombie & Fitch
ANF
$4.42B
– –
-8,514
Closed -$1.07M
AOUT icon
1205
American Outdoor Brands
AOUT
$155M
– –
-13,717
Closed -$106K
APO icon
1206
Apollo Global Management
APO
$72.4B
– –
-2,244
Closed -$325K
APTV icon
1207
Aptiv
APTV
$12B
– –
-2,766
Closed -$210K
ARES icon
1208
Ares Management
ARES
$28.9B
– –
-2,230
Closed -$360K
ARKG icon
1209
ARK Genomic Revolution ETF
ARKG
$1.55B
– –
-76,000
Closed -$2.2M
ARMK icon
1210
Aramark
ARMK
$15B
– –
-12,004
Closed -$442K
ASC icon
1211
Ardmore Shipping
ASC
$710M
– –
-13,944
Closed -$148K
ASH icon
1212
Ashland
ASH
$3.33B
– –
-5,760
Closed -$338K
ASM
1213
Avino Silver & Gold Mines
ASM
$934M
– –
-29,938
Closed -$186K
ATKR icon
1214
Atkore
ATKR
$2.46B
– –
-5,800
Closed -$367K
ATRC icon
1215
AtriCure
ATRC
$1.92B
– –
-6,095
Closed -$241K
ATXS
1216
DELISTED
Astria Therapeutics
ATXS
– –
-529,021
Closed -$6.92M
AVDL
1217
DELISTED
Avadel Pharmaceuticals
AVDL
– –
-31,694
Closed -$683K
AVO icon
1218
Mission Produce
AVO
$1.11B
– –
-18,666
Closed -$217K
AVT icon
1219
Avnet
AVT
$7.29B
– –
-8,734
Closed -$420K
AXP icon
1220
American Express
AXP
$227B
– –
-2,407
Closed -$890K
AXTA icon
1221
Axalta
AXTA
$7.66B
– –
-121,885
Closed -$3.94M
AXSM icon
1222
Axsome Therapeutics
AXSM
$11.2B
– –
-2,129
Closed -$389K
BA icon
1223
Boeing
BA
$171B
– –
-1,160
Closed -$252K
BANF icon
1224
BancFirst
BANF
$3.79B
– –
-2,154
Closed -$228K
BBCA icon
1225
JPMorgan BetaBuilders Canada ETF
BBCA
$10.9B
– –
-4,370
Closed -$406K
47 48
49
50 51

Similar funds

QCM
Qsemble Capital Management New York $1.31B AUM 17.23% 1-Year Est. Return
PFBT
Parkside Financial Bank & Trust Saint Louis, Missouri $1.31B AUM 19.14% 1-Year Est. Return
CCP
Clarkston Capital Partners Rochester, Michigan $1.31B AUM 3.79% 1-Year Est. Return
SP
Sherman Porfolios Coeur D'alene, Idaho $1.3B AUM 35.18% 1-Year Est. Return
WGAM
Wilkinson Global Asset Management New York $1.31B AUM 17.03% 1-Year Est. Return
HCS
Himension Capital (Singapore) Singapore $1.3B AUM 85.53% 1-Year Est. Return
B
BloombergSen Toronto, Ontario, Canada $1.31B AUM 8.32% 1-Year Est. Return
SPC
Silver Point Capital Greenwich, Connecticut $1.3B AUM 18.3% 1-Year Est. Return

Prelude Capital Management's Q1 2026 Portfolio in Review

As of Q1 2026, Prelude Capital Management held 1,682 positions worth $1.31B, down 3.8% from $1.36B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Prelude Capital Management withdrew a net $54.7M in Q1 2026, closing 506 positions and reducing 347 holdings. Its most notable exit was CyberArk, an estimated $15.2M position sold in full.

By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 23% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Prelude Capital Management opened a new position in Appian worth $9.41M.

  • Prelude Capital Management's largest Q1 2026 buy was Appian: 390,321 shares worth $9.41M.
  • Prelude Capital Management added most to Penumbra in Q1 2026, an estimated $15.3M increase.
  • Prelude Capital Management's biggest Q1 2026 reduction was SPDR Gold Trust, cutting an estimated $18.2M.
  • Prelude Capital Management fully exited CyberArk in Q1 2026, selling an estimated $15.2M.
  • Prelude Capital Management's ten largest holdings make up 12% of its $1.31B portfolio in Q1 2026.
  • Prelude Capital Management opened 422 new positions and closed 506 in Q1 2026.
  • Prelude Capital Management's portfolio value fell 3.8% quarter-over-quarter to $1.31B.

Based on Prelude Capital Management's 13F filing for Q1 2026, filed 15 May 2026.